Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuxin Che

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Colloid and Interface Science|February 4, 2015
Control of a catalytic activity of gold nanoparticles embedded in DNA hydrogel by swelling/shrinking the hydrogel's matrixYuxin Che, Anatoly Zinchenko, Shizuaki Murata
International Immunopharmacology|February 12, 2019
Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivoYang Yang, Yuxin Che, Yan Zhao, et al.
Cancer Management and Research|September 29, 2021
Intratumoral Injection of a Human Papillomavirus Therapeutic Vaccine-Induced Strong Anti-TC-1-Grafted Tumor Activity in MiceYuxin Che, Yang Yang, Jinguo Suo, et al.
Plos One|April 15, 2016
Identification of Multi-Functional Enzyme with Multi-Label ClassifierYuxin Che, Ying Ju, Ping Xuan, et al.
Cancer Management and Research|July 21, 2021
Inhibition of Orthotopic Genital Cancer Induced by Subcutaneous Administration of Human Papillomavirus Peptide Vaccine with CpG Oligodeoxynucleotides as an Adjuvant in MiceHuan Wang, Yuxin Che, Yang Yang, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2020
Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancerYuxin Che, Yang Yang, Jinguo Suo, et al.
International Immunopharmacology|November 25, 2020
Anti-pulmonary metastases from cervical cancer responses induced by a human papillomavirus peptide vaccine adjuvanted with CpG-oligodeoxynucleotides in vivoJinguo Suo, Yang Yang, Yuxin Che, et al.
International Immunopharmacology|February 8, 2018
Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 miceXingxuan Wang, Yuxin Che, Bingnan Chen, et al.
ACS Infectious Diseases|November 7, 2022
Correlation of the Gut Microbiota and Antitumor Immune Responses Induced by a Human Papillomavirus Therapeutic VaccineYuxin Che, Shihan Fu, Huan Wang, et al.
Frontiers in Genetics|November 21, 2022
A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulatorsDan Pu, Dan Liu, Can Li, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Colloid and Interface Science|February 4, 2015
Control of a catalytic activity of gold nanoparticles embedded in DNA hydrogel by swelling/shrinking the hydrogel's matrixYuxin Che, Anatoly Zinchenko, Shizuaki Murata
International Immunopharmacology|February 12, 2019
Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivoYang Yang, Yuxin Che, Yan Zhao, et al.
Cancer Management and Research|September 29, 2021
Intratumoral Injection of a Human Papillomavirus Therapeutic Vaccine-Induced Strong Anti-TC-1-Grafted Tumor Activity in MiceYuxin Che, Yang Yang, Jinguo Suo, et al.
Plos One|April 15, 2016
Identification of Multi-Functional Enzyme with Multi-Label ClassifierYuxin Che, Ying Ju, Ping Xuan, et al.
Cancer Management and Research|July 21, 2021
Inhibition of Orthotopic Genital Cancer Induced by Subcutaneous Administration of Human Papillomavirus Peptide Vaccine with CpG Oligodeoxynucleotides as an Adjuvant in MiceHuan Wang, Yuxin Che, Yang Yang, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2020
Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancerYuxin Che, Yang Yang, Jinguo Suo, et al.
International Immunopharmacology|November 25, 2020
Anti-pulmonary metastases from cervical cancer responses induced by a human papillomavirus peptide vaccine adjuvanted with CpG-oligodeoxynucleotides in vivoJinguo Suo, Yang Yang, Yuxin Che, et al.
International Immunopharmacology|February 8, 2018
Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 miceXingxuan Wang, Yuxin Che, Bingnan Chen, et al.
ACS Infectious Diseases|November 7, 2022
Correlation of the Gut Microbiota and Antitumor Immune Responses Induced by a Human Papillomavirus Therapeutic VaccineYuxin Che, Shihan Fu, Huan Wang, et al.
Frontiers in Genetics|November 21, 2022
A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulatorsDan Pu, Dan Liu, Can Li, et al.
Pageof 2